283 Preclinical development and characterization of allogeneic CAR T cells targeting Claudin18.2-positive tumors

• Zhe Li,
• Barbra Sasu,
• Siler Panowski

Affiliations

Zhe Li

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Barbra Sasu

1Allogene Therapeutics, South San Francisco, CA, USA

Siler Panowski

Allogene Therapeutics, South San Francisco, CA, USA